期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

变应性鼻炎特异性免疫治疗机制 被引量：3

原文传递
导出
摘要 变应性鼻炎的特异性免疫治疗是WHO推荐的惟一能够改变患者免疫状态的治疗方法，应用于临床巳近一个世纪，其临床疗效得到了广泛认可，但其作用机制仍未完全阐明。免疫治疗机制的复杂性为免疫治疗的疗效和安全性增加了不确定因素，限制了免疫治疗的临床发展。本文就近年来变应性鼻炎特异性免疫治疗作用机制的研究进展做一综述，以利于更好的解决变应性鼻炎这一临床顽症。
作者 李艳青 王德辉
机构地区 复旦大学附属眼耳鼻喉科医院耳鼻咽喉科
出处 《国际耳鼻咽喉头颈外科杂志》 2012年第2期63-67,共5页 International Journal of Otolaryngology-Head and Neck Surgery
关键词 脱敏法 免疫(Desensitization Immunologic) 鼻炎 变应性 常年性(Rhinitis ALLERGIC Perennial)
分类号 R765.21 [医药卫生—耳鼻咽喉科]
  • 相关文献

参考文献46

  • 1Cingi C, Kayabasoglu G, Nacar A. Update on the medical treatment of allergic rhinitis. Inflamm Allergy Drug Targets, 2009, 8 (2) : 96-103.
  • 2Thomas M. Allergic rhinitis: evidence for impact on asthma. BMCPulmMed, 2006, 6 (Suppl 1) : S4.
  • 3Jacobsen L, Niggemann 13, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy, 2007, 62 (8) .. 943-948.
  • 4Han DH, Rhee CS. Sublingual immunotherapy in allergic rhinitis. Asia Pacific Allergy , 2011, 1 (3): 123-129.
  • 5Radulovic S, Wilson D, Calderon M, et al. Systematic reviews of sublingual immunotherapy (SLIT). Allergy, 2011, 66 (6) : 740-752.
  • 6Wachholz PA, Soni NK, Till SJ, et al. Inhibition ot allergen- IgE binding to B cells by IgG antibodies after grass pollenimmunotherapy. J Allergy Clin Immunol, 2003, 112 (5) :915-922.
  • 7Rodriguez-Perez N, Penagos M, Portnoy JM. New types of immunotherapy in children. Curr Allergy Asthma Rep, 2008, 8 (6) : 484-492.
  • 8Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J AllergyClinlmmunol, 2007, 119 (4) : 780-791.
  • 9Scadding G, Durham SR. Mechanisms of sublingual immunotherapy. Immunol Allergy Clin North AM, 2011, 31 (2) : 191-209.
  • 10Scadding G, Durham S. Mechanism of sublingual immnnotherapy. JAsthma, 2009, 46 (4) .. 322-334.

二级参考文献26

  • 1Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains( CD25 ). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J Immunol, 1995, 155 : 1151-1164.
  • 2Fei S, Zhen G, Ingrid EG, et al. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis. J Immunol,2006,177 : 1500-1509.
  • 3Chen W, Jin W, Lei KJ, et al. Conversion of peripheral CD4^+ CD25^- naive T cell to CD4^+ CD25^+ regulatory T cell by TGF-13 induction of transcription factor Foxp3. J Exp Med,2003,198: 1875-1886.
  • 4Annunziato F, Cosmi L, Liotta F, et al. Phenotype, localization and mechanism of suppression of CD4^+ CD25^+ human thymocytes. J Exp Med, 2002, 196:379-387.
  • 5Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003, 171:6323- 6327.
  • 6Zhang X, Izikson L, Liu L, et al. Activation of CD25( + ) CD4 ( + ) regulatory T cells by oral antigen administration. J Immunol, 2001,167:4245-4253.
  • 7Nemuko O, Yesei O, Motoko Y, et al. Ovalbumin-specific IgE modulates Ovalbumin -specific T-cell response after repetitive oral antigen administration. Allergy Clin Immunol, 2005, 115,822- 827.
  • 8Hauet-Broere F, Unger WW, Garssen J, et al. Functional CD25^- and CD25^+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol,2003 ,33 :2801-2810.
  • 9Dubois B, Goubier A, Joubert G, et al. Oral tolerance and regulation of mucosal immunity. Cell Mol Life Sci ,2005,62 : 1322- 1332.
  • 10Cederbom L, Hall H, Ivars F. CD4^+ CD25^+ regulatory T cells downregulate costimulatory molecules on antigen-presenting cells. Eur J Immunol, 2000,3 : 1538-1543.

共引文献11

同被引文献28

引证文献3

二级引证文献4

国际耳鼻咽喉头颈外科杂志
2012年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部